Skip to main content
. Author manuscript; available in PMC: 2014 Apr 28.
Published in final edited form as: Circ Heart Fail. 2008 Nov;1(4):213–219. doi: 10.1161/CIRCHEARTFAILURE.108.796789

Figure 2.

Figure 2

Effect of Sildenafil on cardiac output (CO), mean pulmonary artery pressure (mPAP), pulmonary capillary wedge pressure (PCWP), and pulmonary vascular resistance (PVR) on patients treated with LVAD and with persistent pulmonary hypertension. N indicates number of patients. * P<0.05 vs. pre-sildenafil. Comparisons made with paired t-test.